Advertisement
Screener

Eton Pharmaceuticals, Inc. (ETON) Other

Eton Pharmaceuticals, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-19: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 par value · ETON · NASDAQ.
  • 2025-11-06: Form 10-Q; Item Current in its reporting; As filed No.
  • 2025-08-07: Form 10-Q; Item Current in its reporting; As filed No.
  • 2025-05-13: Form 10-Q; Item Current in its reporting; As filed No.
FiledFormItemAs filed
2026-03-1910-KStock registered under Section 12(b)Common Stock, $0.001 par value · ETON · NASDAQ
2025-11-0610-QCurrent in its reportingNo
2025-08-0710-QCurrent in its reportingNo
2025-05-1310-QCurrent in its reportingNo
2025-03-1810-KStock registered under Section 12(b)Common Stock, $0.001 par value · ETON · NASDAQ
2025-03-1810-KCurrent in its reportingNo
2024-03-2210-K/AStock registered under Section 12(b)Common Stock, $0.001 par value · ETON · NASDAQ
2024-03-1410-KStock registered under Section 12(b)Common Stock, $0.001 par value · ETON · NASDAQ
2023-11-0910-QEmerging growth companyYes
2023-08-1010-QEmerging growth companyYes
2023-05-1110-QEmerging growth companyYes
2023-03-1610-KStock registered under Section 12(b)Common Stock, $0.001 par value · ETON · NASDAQ
2023-03-1610-KEmerging growth companyYes
2022-11-1010-QStock registered under Section 12(b)Common stock, $0.001 par value per share · ETON · NASDAQ
2022-11-1010-QEmerging growth companyYes
2022-08-1110-QStock registered under Section 12(b)Common stock, $0.001 par value per share · ETON · NASDAQ
2022-08-1110-QEmerging growth companyYes
2022-05-1210-QStock registered under Section 12(b)Common stock, $0.001 par value per share · ETON · NASDAQ
2022-05-1210-QEmerging growth companyYes
2022-03-1610-KStock registered under Section 12(b)Common Stock, $0.001 par value · ETON · NASDAQ
2022-03-1610-KEmerging growth companyYes
2021-11-1610-QStock registered under Section 12(b)Common stock, $0.001 par value per share · ETON · NASDAQ
2021-11-1610-QEmerging growth companyYes
2021-08-1610-QStock registered under Section 12(b)Common stock, $0.001 par value per share · ETON · NASDAQ
2021-08-1610-QEmerging growth companyYes
2021-05-1310-QEmerging growth companyYes
2021-03-1610-KEmerging growth companyYes
2020-11-1210-QEmerging growth companyYes
2020-08-1210-QEmerging growth companyYes
2020-05-1410-QEmerging growth companyYes
2020-03-0510-KEmerging growth companyYes
2019-11-1410-QEmerging growth companyYes
2019-08-0610-QEmerging growth companyYes
2019-05-0710-QEmerging growth companyYes
2019-03-2510-KEmerging growth companyYes
2018-12-2010-QEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xencor Inc (XNCR)United States$1.776B-7.33
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Septerna, Inc. (SEPN)United States$1.783B-63.01
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
COMPASS Pathways plc (CMPS)$1.812B-4.87
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20